Cargando…
Increased [(18)F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
BACKGROUND: [(18)F]Fluoromisonidazole ([(18)F]FMISO) is a PET imaging probe widely used for the detection of hypoxia. We previously reported that [(18)F]FMISO is metabolized to the glutathione conjugate of the reduced form in hypoxic cells. In addition, we found that the [(18)F]FMISO uptake level va...
Autores principales: | Shimizu, Yoichi, Nakai, Yukihiro, Watanabe, Hiroyuki, Iikuni, Shimpei, Ono, Masahiro, Saji, Hideo, Kuge, Yuji, Saga, Tsuneo, Nakamoto, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835267/ https://www.ncbi.nlm.nih.gov/pubmed/33492449 http://dx.doi.org/10.1186/s13550-021-00752-3 |
Ejemplares similares
-
PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide
por: Iikuni, Shimpei, et al.
Publicado: (2020) -
The accumulation mechanism of the hypoxia imaging probe “FMISO” by imaging mass spectrometry: possible involvement of low-molecular metabolites
por: Masaki, Yukiko, et al.
Publicado: (2015) -
FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state
por: Masaki, Yukiko, et al.
Publicado: (2017) -
Cancer radiotheranostics targeting carbonic anhydrase-IX with (111)In- and (90)Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
por: Iikuni, Shimpei, et al.
Publicado: (2018) -
Development of Technetium-99m-Labeled BODIPY-Based Probes Targeting Lipid Droplets Toward the Diagnosis of Hyperlipidemia-Related Diseases
por: Shimizu, Yoichi, et al.
Publicado: (2019)